Literature DB >> 7617854

Ductal carcinoma in situ: MR imaging-histopathologic correlation.

R Gilles1, B Zafrani, J M Guinebretière, M Meunier, O Lucidarme, A A Tardivon, F Rochard, D Vanel, S Neuenschwander, R Arriagada.   

Abstract

PURPOSE: To correlate histopathologic and magnetic resonance (MR) imaging findings of ductal carcinoma in situ (DCIS).
MATERIALS AND METHODS: Thirty-six women with DCIS underwent preoperative contrast material-enhanced subtraction dynamic MR imaging. Concomitant early contrast enhancement in the breast parenchyma with normal vessels was considered a positive finding. The size and shape of early enhancement were correlated with the size and density packing of ducts involved by DCIS. Tumor angiogenesis in the stroma that surrounded the ducts was evaluated with immunoperoxidase staining.
RESULTS: Early contrast enhancement was demonstrated in 34 patients with DCIS but not in two patients with comedo-type DCIS. Tumor angiogenesis was demonstrated in the stroma. The size and morphology of contrast-enhanced lesions significantly correlated with the size (P = .0085) and density packing of ducts involved by DCIS (P = .012).
CONCLUSION: Contrast enhancement on dynamic MR images of DCIS may be due to the presence of tumor angiogenesis in the stroma.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7617854     DOI: 10.1148/radiology.196.2.7617854

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  31 in total

1.  Kinetic analysis of lesions without mass effect on breast MRI using manual and computer-assisted methods.

Authors:  Tibor Vag; Pascal A T Baltzer; Matthias Dietzel; Ramy Zoubi; Mieczyslaw Gajda; Oumar Camara; Werner A Kaiser
Journal:  Eur Radiol       Date:  2010-11-10       Impact factor: 5.315

2.  Value of pre-operative breast MRI for the size assessment of ductal carcinoma in situ.

Authors:  Francesca Proulx; José A Correa; Romuald Ferré; Atilla Omeroglu; Ann Aldis; Sarkis Meterissian; Benoît Mesurolle
Journal:  Br J Radiol       Date:  2015-11-16       Impact factor: 3.039

3.  Ductal carcinoma in situ: correlations between high-resolution magnetic resonance imaging and histopathology.

Authors:  Yoshihide Kanemaki; Yasuyuki Kurihara; Kyoko Okamoto; Yasuo Nakajima; Mamoru Fukuda; Ichiro Maeda; Futoshi Akiyama
Journal:  Radiat Med       Date:  2007-01-25

Review 4.  Imaging tumour angiogenesis.

Authors:  Tony Jeswani; Anwar R Padhani
Journal:  Cancer Imaging       Date:  2005-12-01       Impact factor: 3.909

5.  The clinical value of bilateral breast MR imaging: is it worth performing on patients showing suspicious microcalcifications on mammography?

Authors:  Ayano Akita; Akihiro Tanimoto; Hiromitsu Jinno; Kaori Kameyama; Sachio Kuribayashi
Journal:  Eur Radiol       Date:  2009-04-07       Impact factor: 5.315

6.  DCEMRI of breast lesions: is kinetic analysis equally effective for both mass and nonmass-like enhancement?

Authors:  Sanaz A Jansen; Xiaobing Fan; Gregory S Karczmar; Hiroyuki Abe; Robert A Schmidt; Maryellen Giger; Gillian M Newstead
Journal:  Med Phys       Date:  2008-07       Impact factor: 4.071

7.  What is the sensitivity of mammography and dynamic MR imaging for DCIS if the whole-breast histopathology is used as a reference standard?

Authors:  F Sardanelli; L Bacigalupo; L Carbonaro; A Esseridou; G M Giuseppetti; P Panizza; V Lattanzio; A Del Maschio
Journal:  Radiol Med       Date:  2008-07-09       Impact factor: 3.469

8.  Size assessment of breast lesions by means of a computer-aided detection (CAD) system for magnetic resonance mammography.

Authors:  G Levrini; R Sghedoni; C Mori; A Botti; R Vacondio; A Nitrosi; M Iori; F Nicoli
Journal:  Radiol Med       Date:  2011-03-19       Impact factor: 3.469

9.  In situ and minimally invasive breast cancer: morphologic and kinetic features on contrast-enhanced MR imaging.

Authors:  P Viehweg; D Lampe; J Buchmann; S H Heywang-Köbrunner
Journal:  MAGMA       Date:  2000-12       Impact factor: 2.310

10.  A reference agent model for DCE MRI can be used to quantify the relative vascular permeability of two MRI contrast agents.

Authors:  Julio Cárdenas-Rodríguez; Christine M Howison; Terry O Matsunaga; Mark D Pagel
Journal:  Magn Reson Imaging       Date:  2013-04-11       Impact factor: 2.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.